91 related articles for article (PubMed ID: 11824966)
1. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis.
Fabris M; Di Poi E; D'Elia A; Damante G; Sinigaglia L; Ferraccioli G
J Rheumatol; 2002 Jan; 29(1):29-33. PubMed ID: 11824966
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans.
Rodríguez-Carreón AA; Zúñiga J; Hernández-Pacheco G; Rodríguez-Pérez JM; Pérez-Hernández N; Montes de Oca JV; Cardiel MH; Granados J; Vargas-Alarcón G
J Autoimmun; 2005 Feb; 24(1):63-8. PubMed ID: 15725578
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A
J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women.
Padyukov L; Hytönen AM; Smolnikova M; Hahn-Zoric M; Nilsson N; Hanson LA; Tarkowski A; Klareskog L
J Rheumatol; 2004 Mar; 31(3):422-5. PubMed ID: 14994383
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
8. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis.
Maksymowych WP; Suarez-Almazor ME; Buenviaje H; Cooper BL; Degeus C; Thompson M; Russell AS
J Rheumatol; 2002 Nov; 29(11):2319-26. PubMed ID: 12415587
[TBL] [Abstract][Full Text] [Related]
9. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
Glossop JR; Dawes PT; Hassell AB; Mattey DL
J Rheumatol; 2005 Sep; 32(9):1673-8. PubMed ID: 16142859
[TBL] [Abstract][Full Text] [Related]
10. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.
Cuchacovich M; Ferreira L; Aliste M; Soto L; Cuenca J; Cruzat A; Gatica H; Schiattino I; Pérez C; Aguirre A; Salazar-Onfray F; Aguillón JC
Scand J Rheumatol; 2004; 33(4):228-32. PubMed ID: 15370717
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis.
Mugnier B; Balandraud N; Darque A; Roudier C; Roudier J; Reviron D
Arthritis Rheum; 2003 Jul; 48(7):1849-52. PubMed ID: 12847678
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis.
Schotte H; Schlüter B; Drynda S; Willeke P; Tidow N; Assmann G; Domschke W; Kekow J; Gaubitz M
Ann Rheum Dis; 2005 Apr; 64(4):575-81. PubMed ID: 15345504
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Florczak M; Ostanek L; Brzosko M; Brzosko I; Szklarz BG
Scand J Rheumatol; 2005; 34(1):22-6. PubMed ID: 15903021
[TBL] [Abstract][Full Text] [Related]
16. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
[TBL] [Abstract][Full Text] [Related]
17. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
Manchanda PK; Kumar A; Kaul A; Mittal RD
Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients.
Agrawal C; Raghav SK; Gupta B; Das RH; Chaturvedi VP; Goswami K; Das HR
Arch Med Res; 2005; 36(5):555-9. PubMed ID: 16099338
[TBL] [Abstract][Full Text] [Related]
19. Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients.
Hussein YM; Mohamed RH; Pasha HF; El-Shahawy EE; Alzahrani SS
Cell Immunol; 2011; 271(1):192-6. PubMed ID: 21777909
[TBL] [Abstract][Full Text] [Related]
20. Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.
Guis S; Balandraud N; Bouvenot J; Auger I; Toussirot E; Wendling D; Mattei JP; Nogueira L; Mugnier B; Legeron P; Landt O; Serre G; Roudier J; Roudier C
Arthritis Rheum; 2007 Dec; 57(8):1426-30. PubMed ID: 18050183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
